HEART OF AUSTRALIA RESEARCH INSTITUTE: RESEARCH TRIAL
EasiProtkt Trial
Focus on hypertension with Type 2 Diabetes and cardiovascular disease.
This trial is a Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the investigational product compared with placebo in participants with type 2 diabetes, hypertension and established cardiovascular disease.
